ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Daiichi Sankyo Co Ltd (PK)

Daiichi Sankyo Co Ltd (PK) (DSKYF)

28.84
0.00
( 0.00% )
更新日時: 02:32:46

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
28.84
買値
25.80
売値
28.75
出来高
18,854
25.80 日の範囲 28.84
25.45 52 週間の範囲 44.64
時価総額
前日終値
28.84
始値
25.96
時刻
8
@
27.4
最終取引時間
01:42:49
財務取引量
US$ 497,286
VWAP
26.3756
平均取引量 (3 か月)
13,059
発行済株式数
1,916,787,029
配当利回り
16,405.86%
PER
0.28
1 株当たり利益 (EPS)
104.72
歳入
1.63T
純利益
200.73B

Daiichi Sankyo Co Ltd (PK) について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Biolog/vaccines
ウェブサイト
本社
Chuo, Tokyo, Jpn
設立
2005
Daiichi Sankyo Co Ltd (PK) is listed in the Pharmaceutical Preparations sector of the その他OTC with ticker DSKYF. The last closing price for Daiichi Sankyo (PK) was US$28.84. Over the last year, Daiichi Sankyo (PK) shares have traded in a share price range of US$ 25.45 to US$ 44.64.

Daiichi Sankyo (PK) currently has 1,916,787,029 shares in issue. The market capitalisation of Daiichi Sankyo (PK) is US$55.28 billion. Daiichi Sankyo (PK) has a price to earnings ratio (PE ratio) of 0.28.

DSKYF 最新ニュース

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

Patients with Hypertension at Risk Due to Physician Inertia

Patients with Hypertension at Risk Due to Physician Inertia - New Supporting Hypertension Awareness and Research Europe-wide (SHARE) Survey Reports Findings at the 20th Annual Society of the...

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban - Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan PR Newswire TOKYO, April...

Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs

Bolsters Company's Expertise in Areas of Oncology and Hematology PARSIPPANY, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. (DSI) announced today that Jay M. Feingold, M.D., Ph.D...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
12.6810.24464831826.1629.825.5868127.00644481CS
40.983.517587939727.8631.4925.452960727.36631163CS
12-2.96-9.3081761006331.834.7525.451305928.3138921CS
26-8.29-22.326959332137.1344.6425.45726830.02599905CS
520.010.034686090877628.8344.6425.451200031.11070826CS
1565.9926.214442013122.8544.6419.45862330.09620244CS
260-36.61-55.93582887765.4595.9617.61665229.83932349CS

DSKYF - Frequently Asked Questions (FAQ)

What is the current Daiichi Sankyo (PK) share price?
The current share price of Daiichi Sankyo (PK) is US$ 28.84
How many Daiichi Sankyo (PK) shares are in issue?
Daiichi Sankyo (PK) has 1,916,787,029 shares in issue
What is the market cap of Daiichi Sankyo (PK)?
The market capitalisation of Daiichi Sankyo (PK) is USD 55.28B
What is the 1 year trading range for Daiichi Sankyo (PK) share price?
Daiichi Sankyo (PK) has traded in the range of US$ 25.45 to US$ 44.64 during the past year
What is the PE ratio of Daiichi Sankyo (PK)?
The price to earnings ratio of Daiichi Sankyo (PK) is 0.28
What is the cash to sales ratio of Daiichi Sankyo (PK)?
The cash to sales ratio of Daiichi Sankyo (PK) is 0.03
What is the reporting currency for Daiichi Sankyo (PK)?
Daiichi Sankyo (PK) reports financial results in JPY
What is the latest annual turnover for Daiichi Sankyo (PK)?
The latest annual turnover of Daiichi Sankyo (PK) is JPY 1.63T
What is the latest annual profit for Daiichi Sankyo (PK)?
The latest annual profit of Daiichi Sankyo (PK) is JPY 200.73B
What is the registered address of Daiichi Sankyo (PK)?
The registered address for Daiichi Sankyo (PK) is 3-5-1 NIHONBASHI-HONCHO, CHUO-KU, CHUO, TOKYO, 103-8426
What is the Daiichi Sankyo (PK) website address?
The website address for Daiichi Sankyo (PK) is www.daiichisankyo.co.jp
Which industry sector does Daiichi Sankyo (PK) operate in?
Daiichi Sankyo (PK) operates in the PHARMACEUTICAL BIOLOG/VACCINES sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
477
EATREastern Asteria Inc (CE)
US$ 0.0003
(29,900.00%)
3.59M
PRMOProm Resources Inc (PK)
US$ 0.0001
(9,900.00%)
105k
RBSHRebus Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
402
ZAAGZA Group Inc (PK)
US$ 0.0001
(9,900.00%)
50k
FPWMCharlestowne Premium Beverages Inc (CE)
US$ 0.000001
(-100.00%)
1,000
CRGPCalissio Resources Group Inc (CE)
US$ 0.000001
(-99.75%)
28k
NEOMNeoMedia Technologies Inc (CE)
US$ 0.000001
(-99.50%)
736
NOXLNoxel Corp (CE)
US$ 0.000001
(-99.00%)
59.9k
TMGIMarquie Group Inc (PK)
US$ 0.000001
(-99.00%)
4.53M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(-50.00%)
236.99M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0037
(-19.57%)
231.23M
ASIIAccredited Solutions Inc (PK)
US$ 0.0006
(20.00%)
166.63M
NSAVNet Savings Link Inc (PK)
US$ 0.0005
(0.00%)
159.36M
TKMOTekumo Inc (PK)
US$ 0.00025
(-16.67%)
145.76M

最近閲覧した銘柄

Delayed Upgrade Clock